Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Female Genital Warts”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 0 results

Early research (Phase 1)Study completedNCT03813940
What this trial is testing

Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)

Who this might be right for
Condylomata AcuminataCervical Cancer
Xiamen University 24
Testing effectiveness (Phase 2)Study completedNCT00260039
What this trial is testing

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Who this might be right for
HPVCervical CancerPremalignancy Anogenital Warts
Merck Sharp & Dohme LLC 680
Large-scale testing (Phase 3)Study completedNCT00517309
What this trial is testing

Study to Test the Safety of HPV Vaccine in Women (V501-011)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 1,877
Not applicableStudy completedNCT02188004
What this trial is testing

The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases

Who this might be right for
Human Papillomavirus InfectionGenital Warts
Jun Zhang 4,691
Not applicableStudy completedNCT04796090
What this trial is testing

Genital Wart and Sexuality in Adolescence

Who this might be right for
Adolescent DevelopmentGenital WartSexual Dysfunction+1 more
Ankara City Hospital Bilkent 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05662020
What this trial is testing

Evaluate the Immunogenicity and Safety of HPV Vaccine in Healthy Female Participants Aged 9-26 Years in China

Who this might be right for
Human Papillomavirus Infection
Beijing Health Guard Biotechnology, Inc 2,750
Not applicableStudy completedNCT02558803
What this trial is testing

HPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3

Who this might be right for
Human Papilloma Virus Infection Type 11Human Papilloma Virus Infection Type 16Human Papilloma Virus Infection Type 18+4 more
Regenstrief Institute, Inc. 1,305
Large-scale testing (Phase 3)Active Not RecruitingNCT05056402
What this trial is testing

An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old

Who this might be right for
Cervical CancerCondylomata Acuminata
Xiamen University 1,382
Not applicableStudy completedNCT01192282
What this trial is testing

Typing of Human Papilloma Virus (HPV) From Female Genital Warts

Who this might be right for
Genital WartsHuman Papilloma Virus
University of Cape Town 156
Large-scale testing (Phase 3)Study completedNCT03546842
What this trial is testing

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

Who this might be right for
Papillomavirus InfectionsUterine Cervical NeoplasmsVulvar Neoplasms+3 more
Merck Sharp & Dohme LLC 201
Large-scale testing (Phase 3)Study completedNCT05372016
What this trial is testing

Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
HPV InfectionsCervical CancerVulvar Cancer+12 more
Shanghai Bovax Biotechnology Co., Ltd. 1,200
Large-scale testing (Phase 3)Study completedNCT00501137
What this trial is testing

A Controlled Trial to Assess the Immunogenicity of a Proposed Paediatric Dosing Schedule of Human Papillomavirus Vaccine

Who this might be right for
Cervical CancerGenital Warts
Simon Dobson 830
Testing effectiveness (Phase 2)Study completedNCT05694728
What this trial is testing

A Phase II Trial Evaluate the Immunogenicity and Safety Profile of HPV Vaccine

Who this might be right for
Human Papilloma Virus Infection
Beijing Health Guard Biotechnology, Inc 780
Large-scale testing (Phase 3)Study completedNCT00092521
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 5,759
Large-scale testing (Phase 3)Study completedNCT04425291
What this trial is testing

Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 1,680
Large-scale testing (Phase 3)Looking for participantsNCT04422366
What this trial is testing

Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females

Who this might be right for
Cervical CancerVulvar CancerVaginal Cancer+11 more
Shanghai Bovax Biotechnology Co., Ltd. 8,000
Early research (Phase 1)Study completedNCT00851643
What this trial is testing

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

Who this might be right for
Human Papilloma VirusCervical CancerVulvar Cancer+2 more
Merck Sharp & Dohme LLC 158